{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:37:54Z","timestamp":1786714674805,"version":"build-2736575974"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12587-z","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:11:07Z","timestamp":1786713067000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Induced pluripotent stem cell\u2013derived macrophages (iMacs) in translational medicine: Disease models, drug testing, and therapeutic applications"],"prefix":"10.1007","volume":"53","author":[{"given":"Tara Nur","family":"Amalina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haydar","family":"Alsagaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina Lazimmatus","family":"Sofa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shofiyah","family":"Shofiyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bunga Fadhilah","family":"Sunaryo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keila","family":"Lova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achmad","family":"Zakky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernawan","family":"Febrianto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizal","family":"Azis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"12587_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.immuni.2014.06.013","volume":"41","author":"S Epelman","year":"2014","unstructured":"Epelman S, Lavine KJ, Randolph GJ (2014) Origin and Functions of Tissue Macrophages. Immunity 41:21\u201335. https:\/\/doi.org\/10.1016\/j.immuni.2014.06.013","journal-title":"Immunity"},{"key":"12587_CR2","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1194637","volume":"330","author":"F Ginhoux","year":"2010","unstructured":"Ginhoux F, Greter M, Leboeuf M et al (2010) Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages. Science 330:841\u2013845. https:\/\/doi.org\/10.1126\/science.1194637","journal-title":"Science"},{"key":"12587_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1126\/science.1219179","volume":"336","author":"C Schulz","year":"2012","unstructured":"Schulz C, Perdiguero EG, Chorro L et al (2012) A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells. Science 336:86\u201390. https:\/\/doi.org\/10.1126\/science.1219179","journal-title":"Science"},{"key":"12587_CR4","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.immuni.2015.03.011","volume":"42","author":"G Hoeffel","year":"2015","unstructured":"Hoeffel G, Chen J, Lavin Y et al (2015) C-Myb+ Erythro-Myeloid Progenitor-Derived Fetal Monocytes Give Rise to Adult Tissue-Resident Macrophages. Immunity 42:665\u2013678. https:\/\/doi.org\/10.1016\/j.immuni.2015.03.011","journal-title":"Immunity"},{"key":"12587_CR5","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1084\/jem.20131199","volume":"210","author":"M Guilliams","year":"2013","unstructured":"Guilliams M, De Kleer I, Henri S et al (2013) Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J Exp Med 210:1977\u20131992. https:\/\/doi.org\/10.1084\/jem.20131199","journal-title":"J Exp Med"},{"key":"12587_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.immuni.2016.02.024","volume":"44","author":"F Ginhoux","year":"2016","unstructured":"Ginhoux F, Guilliams M (2016) Tissue-Resident Macrophage Ontogeny and Homeostasis. Immunity 44:439\u2013449. https:\/\/doi.org\/10.1016\/j.immuni.2016.02.024","journal-title":"Immunity"},{"key":"12587_CR7","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.immuni.2020.05.014","volume":"52","author":"C Bl\u00e9riot","year":"2020","unstructured":"Bl\u00e9riot C, Chakarov S, Ginhoux F (2020) Determinants of Resident Tissue Macrophage Identity and Function. Immunity 52:957\u2013970. https:\/\/doi.org\/10.1016\/j.immuni.2020.05.014","journal-title":"Immunity"},{"key":"12587_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41392-025-02124-y","volume":"10","author":"F Guan","year":"2025","unstructured":"Guan F, Wang R, Yi Z et al (2025) Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets. Signal Transduct Target Ther 10:93. https:\/\/doi.org\/10.1038\/s41392-025-02124-y","journal-title":"Signal Transduct Target Ther"},{"key":"12587_CR9","doi-asserted-by":"publisher","unstructured":"Arts RJW, Netea MG (2016) Adaptive Characteristics of Innate Immune Responses in Macrophages. Microbiol Spectr 4. https:\/\/doi.org\/10.1128\/microbiolspec.MCHD-0023-2015","DOI":"10.1128\/microbiolspec.MCHD-0023-2015"},{"key":"12587_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-1311-4","volume-title":"Macrophages: Biology and Role in the Pathology of Diseases","author":"SK Biswas","year":"2014","unstructured":"Biswas SK, Mantovani A (2014) Macrophages: Biology and Role in the Pathology of Diseases. Springer New York, New York, NY"},{"key":"12587_CR11","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1172\/JCI124615","volume":"129","author":"S Watanabe","year":"2019","unstructured":"Watanabe S, Alexander M, Misharin AV, Budinger GRS (2019) The role of macrophages in the resolution of inflammation. J Clin Invest 129:2619\u20132628. https:\/\/doi.org\/10.1172\/JCI124615","journal-title":"J Clin Invest"},{"key":"12587_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn TA, Chawla A, Pollard JW (2013) Macrophage biology in development, homeostasis and disease. Nature 496:445\u2013455. https:\/\/doi.org\/10.1038\/nature12034","journal-title":"Nature"},{"key":"12587_CR13","doi-asserted-by":"publisher","first-page":"e14053","DOI":"10.7717\/peerj.14053","volume":"10","author":"Y Yu","year":"2022","unstructured":"Yu Y, Yue Z, Xu M et al (2022) Macrophages play a key role in tissue repair and regeneration. PeerJ 10:e14053. https:\/\/doi.org\/10.7717\/peerj.14053","journal-title":"PeerJ"},{"key":"12587_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray PJ, Allen JE, Biswas SK et al (2014) Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines. Immunity 41:14\u201320. https:\/\/doi.org\/10.1016\/j.immuni.2014.06.008","journal-title":"Immunity"},{"key":"12587_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.12703\/P6-13","volume":"6","author":"FO Martinez","year":"2014","unstructured":"Martinez FO, Gordon S (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000prime reports 6:13.https:\/\/doi.org\/10.12703\/P6-13","journal-title":"F1000prime reports"},{"key":"12587_CR16","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958\u2013969. https:\/\/doi.org\/10.1038\/nri2448","journal-title":"Nat Rev Immunol"},{"key":"12587_CR17","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.4103\/1673-5374.253510","volume":"14","author":"P Liu","year":"2019","unstructured":"Liu P, Peng J, Han G-H et al (2019) Role of macrophages in peripheral nerve injury and repair. Neural Regen Res 14:1335. https:\/\/doi.org\/10.4103\/1673-5374.253510","journal-title":"Neural Regen Res"},{"key":"12587_CR18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani A, Sica A, Sozzani S et al (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677\u2013686. https:\/\/doi.org\/10.1016\/j.it.2004.09.015","journal-title":"Trends Immunol"},{"key":"12587_CR19","doi-asserted-by":"publisher","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","volume":"164","author":"CD Mills","year":"2000","unstructured":"Mills CD, Kincaid K, Alt JM et al (2000) M-1\/M-2 Macrophages and the Th1\/Th2 Paradigm. J Immunol 164:6166\u20136173. https:\/\/doi.org\/10.4049\/jimmunol.164.12.6166","journal-title":"J Immunol"},{"key":"12587_CR20","doi-asserted-by":"publisher","first-page":"8945","DOI":"10.2147\/JIR.S527764","volume":"18","author":"L Wang","year":"2025","unstructured":"Wang L, Yang K, Xie X et al (2025) Macrophages as Multifaceted Orchestrators of Tissue Repair: Bridging Inflammation, Regeneration, and Therapeutic Innovation. J Inflamm Res Volume 18:8945\u20138959. https:\/\/doi.org\/10.2147\/JIR.S527764","journal-title":"J Inflamm Res Volume"},{"key":"12587_CR21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/ni.1937","volume":"11","author":"SK Biswas","year":"2010","unstructured":"Biswas SK, Mantovani A (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 11:889\u2013896. https:\/\/doi.org\/10.1038\/ni.1937","journal-title":"Nat Immunol"},{"key":"12587_CR22","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1161\/CIRCRESAHA.116.309194","volume":"119","author":"M Nahrendorf","year":"2016","unstructured":"Nahrendorf M, Swirski FK (2016) Abandoning M1\/M2 for a Network Model of Macrophage Function. Circ Res 119:414\u2013417. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309194","journal-title":"Circ Res"},{"key":"12587_CR23","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.3390\/ijms25105491","volume":"25","author":"CAW David","year":"2024","unstructured":"David CAW, Vermeulen JP, Gioria S et al (2024) Nano(bio)Materials Do Not Affect Macrophage Phenotype\u2014A Study Conducted by the REFINE Project. Int J Mol Sci 25:5491. https:\/\/doi.org\/10.3390\/ijms25105491","journal-title":"Int J Mol Sci"},{"key":"12587_CR24","doi-asserted-by":"publisher","first-page":"14049","DOI":"10.1038\/s41598-020-70967-2","volume":"10","author":"OL Gurvich","year":"2020","unstructured":"Gurvich OL, Puttonen KA, Bailey A et al (2020) Transcriptomics uncovers substantial variability associated with alterations in manufacturing processes of macrophage cell therapy products. Sci Rep 10:14049. https:\/\/doi.org\/10.1038\/s41598-020-70967-2","journal-title":"Sci Rep"},{"key":"12587_CR25","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41467-025-56637-9","volume":"16","author":"B Taciak","year":"2025","unstructured":"Taciak B, Bialasek M, Kubiak M et al (2025) Harnessing macrophage-drug conjugates for allogeneic cell-based therapy of solid tumors via the TRAIN mechanism. Nat Commun 16:1327. https:\/\/doi.org\/10.1038\/s41467-025-56637-9","journal-title":"Nat Commun"},{"key":"12587_CR26","doi-asserted-by":"publisher","first-page":"100260","DOI":"10.1016\/j.crmeth.2022.100260","volume":"2","author":"P Aktories","year":"2022","unstructured":"Aktories P, Petry P, Glatz P et al (2022) An improved organotypic cell culture system to study tissue-resident macrophages ex vivo. Cell Rep Methods 2:100260. https:\/\/doi.org\/10.1016\/j.crmeth.2022.100260","journal-title":"Cell Rep Methods"},{"key":"12587_CR27","doi-asserted-by":"publisher","first-page":"1457323","DOI":"10.3389\/fcimb.2024.1457323","volume":"14","author":"M Herb","year":"2024","unstructured":"Herb M, Schatz V, Hadrian K et al (2024) Macrophage variants in laboratory research: most are well done, but some are RAW. Front Cell Infect Microbiol 14:1457323. https:\/\/doi.org\/10.3389\/fcimb.2024.1457323","journal-title":"Front Cell Infect Microbiol"},{"key":"12587_CR28","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.3390\/ijms21134808","volume":"21","author":"S Gutbier","year":"2020","unstructured":"Gutbier S, Wanke F, Dahm N et al (2020) Large-Scale Production of Human iPSC-Derived Macrophages for Drug Screening. Int J Mol Sci 21:4808. https:\/\/doi.org\/10.3390\/ijms21134808","journal-title":"Int J Mol Sci"},{"key":"12587_CR29","doi-asserted-by":"publisher","first-page":"e0243807","DOI":"10.1371\/journal.pone.0243807","volume":"15","author":"S Monkley","year":"2020","unstructured":"Monkley S, Krishnaswamy JK, G\u00f6ransson M et al (2020) Optimised generation of iPSC-derived macrophages and dendritic cells that are functionally and transcriptionally similar to their primary counterparts. PLoS ONE 15:e0243807. https:\/\/doi.org\/10.1371\/journal.pone.0243807","journal-title":"PLoS ONE"},{"key":"12587_CR30","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3390\/cells11111853","volume":"11","author":"MW Nicholson","year":"2022","unstructured":"Nicholson MW, Ting C-Y, Chan DZH et al (2022) Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy. Cells 11:1853. https:\/\/doi.org\/10.3390\/cells11111853","journal-title":"Cells"},{"key":"12587_CR31","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S (2006) Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell 126:663\u2013676. https:\/\/doi.org\/10.1016\/j.cell.2006.07.024","journal-title":"Cell"},{"key":"12587_CR32","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell 131:861\u2013872. https:\/\/doi.org\/10.1016\/j.cell.2007.11.019","journal-title":"Cell"},{"key":"12587_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bioactmat.2024.04.004","volume":"38","author":"Q Guo","year":"2024","unstructured":"Guo Q, Qian Z-M (2024) Macrophage based drug delivery: Key challenges and strategies. Bioact Mater 38:55\u201372. https:\/\/doi.org\/10.1016\/j.bioactmat.2024.04.004","journal-title":"Bioact Mater"},{"key":"12587_CR34","doi-asserted-by":"publisher","first-page":"1640935","DOI":"10.3389\/fimmu.2025.1640935","volume":"16","author":"T Ding","year":"2025","unstructured":"Ding T, Du Y, Yang B et al (2025) Comprehensive review of macrophage models: primary cells and immortalized lines across species. Front Immunol 16:1640935. https:\/\/doi.org\/10.3389\/fimmu.2025.1640935","journal-title":"Front Immunol"},{"key":"12587_CR35","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.stemcr.2016.12.020","volume":"8","author":"J Buchrieser","year":"2017","unstructured":"Buchrieser J, James W, Moore MD (2017) Human Induced Pluripotent Stem Cell-Derived Macrophages Share Ontogeny with MYB-Independent Tissue-Resident Macrophages. Stem Cell Rep 8:334\u2013345. https:\/\/doi.org\/10.1016\/j.stemcr.2016.12.020","journal-title":"Stem Cell Rep"},{"key":"12587_CR36","doi-asserted-by":"publisher","first-page":"640703","DOI":"10.3389\/fcell.2021.640703","volume":"9","author":"I Lyadova","year":"2021","unstructured":"Lyadova I, Gerasimova T, Nenasheva T (2021) Macrophages Derived From Human Induced Pluripotent Stem Cells: The Diversity of Protocols, Future Prospects, and Outstanding Questions. Front Cell Dev Biol 9:640703. https:\/\/doi.org\/10.3389\/fcell.2021.640703","journal-title":"Front Cell Dev Biol"},{"key":"12587_CR37","doi-asserted-by":"publisher","first-page":"16087","DOI":"10.3390\/ijms232416087","volume":"23","author":"A Klepikova","year":"2022","unstructured":"Klepikova A, Nenasheva T, Sheveleva O et al (2022) iPSC-Derived Macrophages: The Differentiation Protocol Affects Cell Immune Characteristics and Differentiation Trajectories. Int J Mol Sci 23:16087. https:\/\/doi.org\/10.3390\/ijms232416087","journal-title":"Int J Mol Sci"},{"key":"12587_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13578-022-00824-4","volume":"12","author":"I Lyadova","year":"2022","unstructured":"Lyadova I, Vasiliev A (2022) Macrophages derived from pluripotent stem cells: prospective applications and research gaps. Cell Biosci 12:96. https:\/\/doi.org\/10.1186\/s13578-022-00824-4","journal-title":"Cell Biosci"},{"key":"12587_CR39","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/gt.2011.22","volume":"18","author":"S Senju","year":"2011","unstructured":"Senju S, Haruta M, Matsumura K et al (2011) Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy. Gene Ther 18:874\u2013883. https:\/\/doi.org\/10.1038\/gt.2011.22","journal-title":"Gene Ther"},{"key":"12587_CR40","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.exphem.2008.04.009","volume":"36","author":"KR Karlsson","year":"2008","unstructured":"Karlsson KR, Cowley S, Martinez FO et al (2008) Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3. Exp Hematol 36:1167\u20131175. https:\/\/doi.org\/10.1016\/j.exphem.2008.04.009","journal-title":"Exp Hematol"},{"key":"12587_CR41","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.stemcr.2019.05.003","volume":"12","author":"X Cao","year":"2019","unstructured":"Cao X, Yakala GK, Van Den Hil FE et al (2019) Differentiation and Functional Comparison of Monocytes and Macrophages from hiPSCs with Peripheral Blood Derivatives. Stem Cell Rep 12:1282\u20131297. https:\/\/doi.org\/10.1016\/j.stemcr.2019.05.003","journal-title":"Stem Cell Rep"},{"key":"12587_CR42","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41596-021-00654-7","volume":"17","author":"M Ackermann","year":"2022","unstructured":"Ackermann M, Rafiei Hashtchin A, Manstein F et al (2022) Continuous human iPSC-macrophage mass production by suspension culture in stirred tank bioreactors. Nat Protoc 17:513\u2013539. https:\/\/doi.org\/10.1038\/s41596-021-00654-7","journal-title":"Nat Protoc"},{"key":"12587_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/biomedicines13010099","volume":"13","author":"Q Hai","year":"2025","unstructured":"Hai Q, Bazeley P, Han J et al (2025) Optimized Method to Generate Well-Characterized Macrophages from Induced Pluripotent Stem Cells. Biomedicines 13:99. https:\/\/doi.org\/10.3390\/biomedicines13010099","journal-title":"Biomedicines"},{"key":"12587_CR44","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3389\/fimmu.2020.01016","volume":"11","author":"T Nenasheva","year":"2020","unstructured":"Nenasheva T, Gerasimova T, Serdyuk Y et al (2020) Macrophages Derived From Human Induced Pluripotent Stem Cells Are Low-Activated Na\u00efve-Like Cells Capable of Restricting Mycobacteria Growth. Front Immunol 11:1016. https:\/\/doi.org\/10.3389\/fimmu.2020.01016","journal-title":"Front Immunol"},{"key":"12587_CR45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1161\/CIRCRESAHA.117.305860","volume":"117","author":"H Zhang","year":"2015","unstructured":"Zhang H, Xue C, Shah R et al (2015) Functional Analysis and Transcriptomic Profiling of iPSC-Derived Macrophages and Their Application in Modeling Mendelian Disease. Circ Res 117:17\u201328. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.305860","journal-title":"Circ Res"},{"key":"12587_CR46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fphar.2018.00071","volume":"9","author":"S Tedesco","year":"2018","unstructured":"Tedesco S, De Majo F, Kim J et al (2018) Convenience versus Biological Significance: Are PMA-Differentiated THP-1 Cells a Reliable Substitute for Blood-Derived Macrophages When Studying in Vitro Polarization? Front Pharmacol 9:71. https:\/\/doi.org\/10.3389\/fphar.2018.00071","journal-title":"Front Pharmacol"},{"key":"12587_CR47","doi-asserted-by":"publisher","first-page":"12524","DOI":"10.1038\/srep12524","volume":"5","author":"K Alasoo","year":"2015","unstructured":"Alasoo K, Martinez FO, Hale C et al (2015) Transcriptional profiling of macrophages derived from monocytes and iPS cells identifies a conserved response to LPS and novel alternative transcription. Sci Rep 5:12524. https:\/\/doi.org\/10.1038\/srep12524","journal-title":"Sci Rep"},{"key":"12587_CR48","doi-asserted-by":"publisher","first-page":"e71098","DOI":"10.1371\/journal.pone.0071098","volume":"8","author":"BV Wilgenburg","year":"2013","unstructured":"Wilgenburg BV, Browne C, Vowles J, Cowley SA (2013) Efficient, Long Term Production of Monocyte-Derived Macrophages from Human Pluripotent Stem Cells under Partly-Defined and Fully-Defined Conditions. PLoS ONE 8:e71098. https:\/\/doi.org\/10.1371\/journal.pone.0071098","journal-title":"PLoS ONE"},{"key":"12587_CR49","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3390\/v16040552","volume":"16","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Qiu H, Duan F et al (2024) A Comparative Study of Human Pluripotent Stem Cell-Derived Macrophages in Modeling Viral Infections. Viruses 16:552. https:\/\/doi.org\/10.3390\/v16040552","journal-title":"Viruses"},{"key":"12587_CR50","doi-asserted-by":"publisher","first-page":"e01563","DOI":"10.1128\/jvi.01563-23","volume":"98","author":"Q Yang","year":"2024","unstructured":"Yang Q, Barbachano-Guerrero A, Fairchild LM et al (2024) Macrophages derived from human induced pluripotent stem cells (iPSCs) serve as a high-fidelity cellular model for investigating HIV-1, dengue, and influenza viruses. J Virol 98:e01563\u2013e01523. https:\/\/doi.org\/10.1128\/jvi.01563-23","journal-title":"J Virol"},{"key":"12587_CR51","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/mt.2010.269","volume":"19","author":"A Kambal","year":"2011","unstructured":"Kambal A, Mitchell G, Cary W et al (2011) Generation of HIV-1 Resistant and Functional Macrophages From Hematopoietic Stem Cell\u2013derived Induced Pluripotent Stem Cells. Mol Ther 19:584\u2013593. https:\/\/doi.org\/10.1038\/mt.2010.269","journal-title":"Mol Ther"},{"key":"12587_CR52","doi-asserted-by":"publisher","unstructured":"Schilling M, Vaughan-Jackson A, James W, McKeating JA (2023) Hypoxia dampens innate immune signalling at early time points and increases Zika virus RNA levels in iPSC-derived macrophages. J Gen Virol 104. https:\/\/doi.org\/10.1099\/jgv.0.001885","DOI":"10.1099\/jgv.0.001885"},{"key":"12587_CR53","doi-asserted-by":"publisher","first-page":"870535","DOI":"10.3389\/fimmu.2022.870535","volume":"13","author":"T Tanaka","year":"2022","unstructured":"Tanaka T, Shiba T, Honda Y et al (2022) Induced Pluripotent Stem Cell-Derived Monocytes\/Macrophages in Autoinflammatory Diseases. Front Immunol 13:870535. https:\/\/doi.org\/10.3389\/fimmu.2022.870535","journal-title":"Front Immunol"},{"key":"12587_CR54","doi-asserted-by":"publisher","first-page":"2203725","DOI":"10.1002\/smll.202203725","volume":"19","author":"L Qi","year":"2023","unstructured":"Qi L, Matsuo K, Pereira A et al (2023) Human iPSC-Derived Proinflammatory Macrophages cause Insulin Resistance in an Isogenic White Adipose Tissue Microphysiological System. Small 19:2203725. https:\/\/doi.org\/10.1002\/smll.202203725","journal-title":"Small"},{"key":"12587_CR55","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1038\/s41467-023-39311-w","volume":"14","author":"M Groeger","year":"2023","unstructured":"Groeger M, Matsuo K, Heidary Arash E et al (2023) Modeling and therapeutic targeting of inflammation-induced hepatic insulin resistance using human iPSC-derived hepatocytes and macrophages. Nat Commun 14:3902. https:\/\/doi.org\/10.1038\/s41467-023-39311-w","journal-title":"Nat Commun"},{"key":"12587_CR56","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/infdis\/jiad141","volume":"228","author":"S Ramalingam","year":"2023","unstructured":"Ramalingam S, Kumar A, Krug S et al (2023) CRISPR Correction of the GBA Mutation in Human-Induced Pluripotent Stem Cells Restores Normal Function to Gaucher Macrophages and Increases Their Susceptibility to Mycobacterium tuberculosis. J Infect Dis 228:777\u2013782. https:\/\/doi.org\/10.1093\/infdis\/jiad141","journal-title":"J Infect Dis"},{"key":"12587_CR57","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.3390\/cells10112822","volume":"10","author":"D Messelodi","year":"2021","unstructured":"Messelodi D, Bertuccio SN, Indio V et al (2021) iPSC-Derived Gaucher Macrophages Display Growth Impairment and Activation of Inflammation-Related Cell Death. Cells 10:2822. https:\/\/doi.org\/10.3390\/cells10112822","journal-title":"Cells"},{"key":"12587_CR58","doi-asserted-by":"publisher","first-page":"18054","DOI":"10.1073\/pnas.1207889109","volume":"109","author":"LM Panicker","year":"2012","unstructured":"Panicker LM, Miller D, Park TS et al (2012) Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease. Proc Natl Acad Sci 109:18054\u201318059. https:\/\/doi.org\/10.1073\/pnas.1207889109","journal-title":"Proc Natl Acad Sci"},{"key":"12587_CR59","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1146\/annurev.med.60.041807.123500","volume":"61","author":"JA Whitsett","year":"2010","unstructured":"Whitsett JA, Wert SE, Weaver TE (2010) Alveolar Surfactant Homeostasis and the Pathogenesis of Pulmonary Disease. Annu Rev Med 61:105\u2013119. https:\/\/doi.org\/10.1146\/annurev.med.60.041807.123500","journal-title":"Annu Rev Med"},{"key":"12587_CR60","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1073\/pnas.91.12.5592","volume":"91","author":"E Stanley","year":"1994","unstructured":"Stanley E, Lieschke GJ, Grail D et al (1994) Granulocyte\/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci 91:5592\u20135596. https:\/\/doi.org\/10.1073\/pnas.91.12.5592","journal-title":"Proc Natl Acad Sci"},{"key":"12587_CR61","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1164\/rccm.201708-1562OC","volume":"198","author":"C Happle","year":"2018","unstructured":"Happle C, Lachmann N, Ackermann M et al (2018) Pulmonary Transplantation of Human Induced Pluripotent Stem Cell\u2013derived Macrophages Ameliorates Pulmonary Alveolar Proteinosis. Am J Respir Crit Care Med 198:350\u2013360. https:\/\/doi.org\/10.1164\/rccm.201708-1562OC","journal-title":"Am J Respir Crit Care Med"},{"key":"12587_CR62","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13195-020-00709-z","volume":"12","author":"H Hall-Roberts","year":"2020","unstructured":"Hall-Roberts H, Agarwal D, Obst J et al (2020) TREM2 Alzheimer\u2019s variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages. Alzheimers Res Ther 12:151. https:\/\/doi.org\/10.1186\/s13195-020-00709-z","journal-title":"Alzheimers Res Ther"},{"key":"12587_CR63","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00401-023-02568-y","volume":"145","author":"F Filipello","year":"2023","unstructured":"Filipello F, You S-F, Mirfakhar FS et al (2023) Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation. Acta Neuropathol (Berl) 145:749\u2013772. https:\/\/doi.org\/10.1007\/s00401-023-02568-y","journal-title":"Acta Neuropathol (Berl)"},{"key":"12587_CR64","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1038\/s41467-020-19227-5","volume":"11","author":"A McQuade","year":"2020","unstructured":"McQuade A, Kang YJ, Hasselmann J et al (2020) Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u2019s disease. Nat Commun 11:5370. https:\/\/doi.org\/10.1038\/s41467-020-19227-5","journal-title":"Nat Commun"},{"key":"12587_CR65","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12974-023-02919-2","volume":"20","author":"N St\u00f6berl","year":"2023","unstructured":"St\u00f6berl N, Maguire E, Salis E et al (2023) Human iPSC-derived glia models for the study of neuroinflammation. J Neuroinflammation 20:231. https:\/\/doi.org\/10.1186\/s12974-023-02919-2","journal-title":"J Neuroinflammation"},{"key":"12587_CR66","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.06.017","volume":"47","author":"K Takata","year":"2017","unstructured":"Takata K, Kozaki T, Lee CZW et al (2017) Induced-Pluripotent-Stem-Cell-Derived Primitive Macrophages Provide a Platform for Modeling Tissue-Resident Macrophage Differentiation and Function. Immunity 47:183\u2013198e6. https:\/\/doi.org\/10.1016\/j.immuni.2017.06.017","journal-title":"Immunity"},{"key":"12587_CR67","doi-asserted-by":"publisher","unstructured":"Armesilla-Diaz A, Pilar Arenaz M, Ashby C et al (2025) High-throughput screening of small molecules targeting Mycobacterium tuberculosis in human iPSC macrophages. Antimicrob Agents Chemother e01613-24 https:\/\/doi.org\/10.1128\/aac.01613-24","DOI":"10.1128\/aac.01613-24"},{"key":"12587_CR68","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.stemcr.2019.10.002","volume":"13","author":"H-W Han","year":"2019","unstructured":"Han H-W, Seo H-H, Jo H-Y et al (2019) Drug Discovery Platform Targeting M. tuberculosis with Human Embryonic Stem Cell-Derived Macrophages. Stem Cell Rep 13:980\u2013991. https:\/\/doi.org\/10.1016\/j.stemcr.2019.10.002","journal-title":"Stem Cell Rep"},{"key":"12587_CR69","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.slasd.2023.04.002","volume":"28","author":"S Bitzer","year":"2023","unstructured":"Bitzer S, Harati MD, El Kasmi KC et al (2023) Application of human iPSC-derived macrophages in a miniaturized high-content-imaging-based efferocytosis assay. SLAS Discov 28:149\u2013162. https:\/\/doi.org\/10.1016\/j.slasd.2023.04.002","journal-title":"SLAS Discov"},{"key":"12587_CR70","doi-asserted-by":"publisher","first-page":"100185","DOI":"10.1016\/j.slasd.2024.100185","volume":"29","author":"MD Harati","year":"2024","unstructured":"Harati MD, King J, Langer S et al (2024) Recapitulation of NOD\/RIPK2 signaling in iPSC-derived macrophages. SLAS Discov 29:100185. https:\/\/doi.org\/10.1016\/j.slasd.2024.100185","journal-title":"SLAS Discov"},{"key":"12587_CR71","doi-asserted-by":"publisher","first-page":"1397886","DOI":"10.3389\/fimmu.2024.1397886","volume":"15","author":"C Rodriguez Gonzalez","year":"2024","unstructured":"Rodriguez Gonzalez C, Bas\u00edlio-Queir\u00f3s D, Neehus A-L et al (2024) Human CFTR deficient iPSC-macrophages reveal impaired functional and transcriptomic response upon Pseudomonas aeruginosa infection. Front Immunol 15:1397886. https:\/\/doi.org\/10.3389\/fimmu.2024.1397886","journal-title":"Front Immunol"},{"key":"12587_CR72","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41597-024-04064-8","volume":"11","author":"G Mahesh","year":"2024","unstructured":"Mahesh G, Martin EW, Aqdas M et al (2024) Whole genome sequencing of CRISPR\/Cas9-engineered NF-\u03baB reporter mice for validation and variant discovery. Sci Data 11:1225. https:\/\/doi.org\/10.1038\/s41597-024-04064-8","journal-title":"Sci Data"},{"key":"12587_CR73","doi-asserted-by":"publisher","first-page":"1236553","DOI":"10.3389\/fcell.2023.1236553","volume":"11","author":"K Shevade","year":"2023","unstructured":"Shevade K, Peddada S, Mader K, Przybyla L (2023) Functional genomics in stem cell models: considerations and applications. Front Cell Dev Biol 11:1236553. https:\/\/doi.org\/10.3389\/fcell.2023.1236553","journal-title":"Front Cell Dev Biol"},{"key":"12587_CR74","doi-asserted-by":"publisher","first-page":"102903","DOI":"10.1016\/j.xpro.2024.102903","volume":"5","author":"E Navarro-Guerrero","year":"2024","unstructured":"Navarro-Guerrero E, Baronio R, Tay C et al (2024) Optimized protocol for CRISPR knockout of human iPSC-derived macrophages. STAR Protoc 5:102903. https:\/\/doi.org\/10.1016\/j.xpro.2024.102903","journal-title":"STAR Protoc"},{"key":"12587_CR75","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13045-020-00983-2","volume":"13","author":"L Zhang","year":"2020","unstructured":"Zhang L, Tian L, Dai X et al (2020) Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions. J Hematol OncolJ Hematol Oncol 13:153. https:\/\/doi.org\/10.1186\/s13045-020-00983-2","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"12587_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2024\/6201728","volume":"2024","author":"M Klimak","year":"2024","unstructured":"Klimak M, Guilak F (2024) Genetically Engineered Macrophages Derived from iPSCs for Self-Regulating Delivery of Anti-Inflammatory Biologic Drugs. J Tissue Eng Regen Med 2024:1\u201311. https:\/\/doi.org\/10.1155\/2024\/6201728","journal-title":"J Tissue Eng Regen Med"},{"key":"12587_CR77","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13287-024-03785-2","volume":"15","author":"M Ackermann","year":"2024","unstructured":"Ackermann M, Saleh F, Abdin SM et al (2024) Standardized generation of human iPSC-derived hematopoietic organoids and macrophages utilizing a benchtop bioreactor platform under fully defined conditions. Stem Cell Res Ther 15:171. https:\/\/doi.org\/10.1186\/s13287-024-03785-2","journal-title":"Stem Cell Res Ther"},{"key":"12587_CR78","doi-asserted-by":"publisher","unstructured":"Hall-Roberts H, Di Daniel E, James WS et al (2021) In vitro Quantitative Imaging Assay for Phagocytosis of Dead Neuroblastoma Cells by iPSC-Macrophages. J Vis Exp 62217. https:\/\/doi.org\/10.3791\/62217","DOI":"10.3791\/62217"},{"key":"12587_CR79","doi-asserted-by":"publisher","first-page":"e0237030","DOI":"10.1371\/journal.pone.0237030","volume":"15","author":"R Seki","year":"2020","unstructured":"Seki R, Ohta A, Niwa A et al (2020) Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity. PLoS ONE 15:e0237030. https:\/\/doi.org\/10.1371\/journal.pone.0237030","journal-title":"PLoS ONE"},{"key":"12587_CR80","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","volume":"10","author":"Y Yang","year":"2019","unstructured":"Yang Y, Wang H, Kouadir M et al (2019) Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis 10:128. https:\/\/doi.org\/10.1038\/s41419-019-1413-8","journal-title":"Cell Death Dis"},{"key":"12587_CR81","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1038\/s41598-021-82137-z","volume":"11","author":"E Navarro-Guerrero","year":"2021","unstructured":"Navarro-Guerrero E, Tay C, Whalley JP et al (2021) Genome-wide CRISPR\/Cas9-knockout in human induced Pluripotent Stem Cell (iPSC)-derived macrophages. Sci Rep 11:4245. https:\/\/doi.org\/10.1038\/s41598-021-82137-z","journal-title":"Sci Rep"},{"key":"12587_CR82","doi-asserted-by":"publisher","first-page":"102420","DOI":"10.1016\/j.stemcr.2025.102420","volume":"20","author":"S Meier","year":"2025","unstructured":"Meier S, Larsen ASG, Wanke F et al (2025) An efficient, non-viral arrayed CRISPR screening platform for iPSC-derived myeloid and microglia models. Stem Cell Rep 20:102420. https:\/\/doi.org\/10.1016\/j.stemcr.2025.102420","journal-title":"Stem Cell Rep"},{"key":"12587_CR83","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.tibtech.2023.02.003","volume":"41","author":"D Xue","year":"2023","unstructured":"Xue D, Lu S, Zhang H et al (2023) Induced pluripotent stem cell-derived engineered T cells, natural killer cells, macrophages, and dendritic cells in immunotherapy. Trends Biotechnol 41:907\u2013922. https:\/\/doi.org\/10.1016\/j.tibtech.2023.02.003","journal-title":"Trends Biotechnol"},{"key":"12587_CR84","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1038\/s41467-022-30557-4","volume":"13","author":"C Alsinet","year":"2022","unstructured":"Alsinet C, Primo MN, Lorenzi V et al (2022) Robust temporal map of human in vitro myelopoiesis using single-cell genomics. Nat Commun 13:2885. https:\/\/doi.org\/10.1038\/s41467-022-30557-4","journal-title":"Nat Commun"},{"key":"12587_CR85","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13287-026-05009-1","volume":"17","author":"M Schinke","year":"2026","unstructured":"Schinke M, Gensch I, Rietschel T et al (2026) Defined culture conditions improve functional properties of mature iPSC-derived macrophages for therapeutic screening. Stem Cell Res Ther 17:134. https:\/\/doi.org\/10.1186\/s13287-026-05009-1","journal-title":"Stem Cell Res Ther"},{"key":"12587_CR86","doi-asserted-by":"publisher","first-page":"e00353","DOI":"10.1128\/mbio.00353-24","volume":"15","author":"C Bussi","year":"2024","unstructured":"Bussi C, Lai R, Athanasiadi N, Gutierrez MG (2024) Physiologic medium renders human iPSC-derived macrophages permissive for M. tuberculosis by rewiring organelle function and metabolism. mBio 15:e00353\u2013e00324. https:\/\/doi.org\/10.1128\/mbio.00353-24","journal-title":"mBio"},{"key":"12587_CR87","doi-asserted-by":"publisher","first-page":"1615760","DOI":"10.3389\/fimmu.2025.1615760","volume":"16","author":"A Morva","year":"2025","unstructured":"Morva A, Arroyo AB, Andreeva L et al (2025) Unleashing the power of CAR-M therapy in solid tumors: a comprehensive review. Front Immunol 16:1615760. https:\/\/doi.org\/10.3389\/fimmu.2025.1615760","journal-title":"Front Immunol"},{"key":"12587_CR88","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41698-025-01170-7","volume":"9","author":"M Alrehaili","year":"2025","unstructured":"Alrehaili M, Couto PS, Khalife R, Rafiq QA (2025) CAR-macrophages in solid tumors: promise, progress, and prospects. Npj Precis Oncol 9:382. https:\/\/doi.org\/10.1038\/s41698-025-01170-7","journal-title":"Npj Precis Oncol"},{"key":"12587_CR89","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40364-024-00637-2","volume":"12","author":"J Lu","year":"2024","unstructured":"Lu J, Ma Y, Li Q et al (2024) CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond. Biomark Res 12:86. https:\/\/doi.org\/10.1186\/s40364-024-00637-2","journal-title":"Biomark Res"},{"key":"12587_CR90","doi-asserted-by":"publisher","first-page":"5778","DOI":"10.1038\/s41467-023-41470-9","volume":"14","author":"X Wang","year":"2023","unstructured":"Wang X, Su S, Zhu Y et al (2023) Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors. Nat Commun 14:5778. https:\/\/doi.org\/10.1038\/s41467-023-41470-9","journal-title":"Nat Commun"},{"key":"12587_CR91","doi-asserted-by":"publisher","first-page":"105390","DOI":"10.1016\/j.ebiom.2024.105390","volume":"109","author":"X Zhen","year":"2024","unstructured":"Zhen X, Kim J, Kang JS et al (2024) Homology-independent targeted insertion-mediated derivation of M1-biased macrophages harbouring Megf10 and CD3\u03b6 from human pluripotent stem cells. eBioMedicine 109:105390. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105390","journal-title":"eBioMedicine"},{"key":"12587_CR92","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13045-024-01635-5","volume":"17","author":"X Li","year":"2024","unstructured":"Li X, Wang X, Wang H et al (2024) A clinical study of autologous chimeric antigen receptor macrophage targeting mesothelin shows safety in ovarian cancer therapy. J Hematol OncolJ Hematol Oncol 17:116. https:\/\/doi.org\/10.1186\/s13045-024-01635-5","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"12587_CR93","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/path.5275","volume":"248","author":"J Han","year":"2019","unstructured":"Han J, Zhang X, Lau JK et al (2019) Bone marrow-derived macrophage contributes to fibrosing steatohepatitis through activating hepatic stellate cells. J Pathol 248:488\u2013500. https:\/\/doi.org\/10.1002\/path.5275","journal-title":"J Pathol"},{"key":"12587_CR94","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3389\/fimmu.2020.01169","volume":"11","author":"H Li","year":"2020","unstructured":"Li H, Zhou Y, Wang H et al (2020) Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis. Front Immunol 11:1169. https:\/\/doi.org\/10.3389\/fimmu.2020.01169","journal-title":"Front Immunol"},{"key":"12587_CR95","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12876-020-01467-w","volume":"20","author":"G Zhang","year":"2020","unstructured":"Zhang G, Wang X, Chung T-Y et al (2020) Carbon tetrachloride (CCl4) accelerated development of non-alcoholic fatty liver disease (NAFLD)\/steatohepatitis (NASH) in MS-NASH mice fed western diet supplemented with fructose (WDF). BMC Gastroenterol 20:339. https:\/\/doi.org\/10.1186\/s12876-020-01467-w","journal-title":"BMC Gastroenterol"},{"key":"12587_CR96","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/stem.3449","volume":"39","author":"S Pouyanfard","year":"2021","unstructured":"Pouyanfard S, Meshgin N, Cruz LS et al (2021) Human Induced Pluripotent Stem Cell-Derived Macrophages Ameliorate Liver Fibrosis. Stem Cells 39:1701\u20131717. https:\/\/doi.org\/10.1002\/stem.3449","journal-title":"Stem Cells"},{"key":"12587_CR97","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.stemcr.2018.07.006","volume":"11","author":"A Mucci","year":"2018","unstructured":"Mucci A, Lopez-Rodriguez E, Hetzel M et al (2018) iPSC-Derived Macrophages Effectively Treat Pulmonary Alveolar Proteinosis in Csf2rb-Deficient Mice. Stem Cell Rep 11:696\u2013710. https:\/\/doi.org\/10.1016\/j.stemcr.2018.07.006","journal-title":"Stem Cell Rep"},{"key":"12587_CR98","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1164\/rccm.201306-1012OC","volume":"189","author":"N Lachmann","year":"2014","unstructured":"Lachmann N, Happle C, Ackermann M et al (2014) Gene Correction of Human Induced Pluripotent Stem Cells Repairs the Cellular Phenotype in Pulmonary Alveolar Proteinosis. Am J Respir Crit Care Med 189:167\u2013182. https:\/\/doi.org\/10.1164\/rccm.201306-1012OC","journal-title":"Am J Respir Crit Care Med"},{"key":"12587_CR99","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1164\/rccm.201306-1039OC","volume":"189","author":"T Suzuki","year":"2014","unstructured":"Suzuki T, Mayhew C, Sallese A et al (2014) Use of Induced Pluripotent Stem Cells to Recapitulate Pulmonary Alveolar Proteinosis Pathogenesis. Am J Respir Crit Care Med 189:183\u2013193. https:\/\/doi.org\/10.1164\/rccm.201306-1039OC","journal-title":"Am J Respir Crit Care Med"},{"key":"12587_CR100","doi-asserted-by":"publisher","first-page":"15195","DOI":"10.1038\/s41598-017-14566-8","volume":"7","author":"A Kuhn","year":"2017","unstructured":"Kuhn A, Ackermann M, Mussolino C et al (2017) TALEN-mediated functional correction of human iPSC-derived macrophages in context of hereditary pulmonary alveolar proteinosis. Sci Rep 7:15195. https:\/\/doi.org\/10.1038\/s41598-017-14566-8","journal-title":"Sci Rep"},{"key":"12587_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2020.12.003","volume":"230","author":"RPH De Maeyer","year":"2021","unstructured":"De Maeyer RPH, Chambers ES (2021) The impact of ageing on monocytes and macrophages. Immunol Lett 230:1\u201310. https:\/\/doi.org\/10.1016\/j.imlet.2020.12.003","journal-title":"Immunol Lett"},{"key":"12587_CR102","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3390\/ijms19030831","volume":"19","author":"S Mammana","year":"2018","unstructured":"Mammana S, Fagone P, Cavalli E et al (2018) The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer\u2019s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets. Int J Mol Sci 19:831. https:\/\/doi.org\/10.3390\/ijms19030831","journal-title":"Int J Mol Sci"},{"key":"12587_CR103","doi-asserted-by":"publisher","first-page":"e17848","DOI":"10.1002\/advs.202417848","volume":"12","author":"VA Moser","year":"2025","unstructured":"Moser VA, Dimas-Harms LJ, Lipman RM et al (2025) Human iPSC\u2010Derived Mononuclear Phagocytes Improve Cognition and Neural Health across Multiple Mouse Models of Aging and Alzheimer\u2019s Disease. Adv Sci 12:e17848. https:\/\/doi.org\/10.1002\/advs.202417848","journal-title":"Adv Sci"},{"key":"12587_CR104","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nm.3569","volume":"20","author":"SA Villeda","year":"2014","unstructured":"Villeda SA, Plambeck KE, Middeldorp J et al (2014) Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat Med 20:659\u2013663. https:\/\/doi.org\/10.1038\/nm.3569","journal-title":"Nat Med"},{"key":"12587_CR105","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s42003-020-0797-4","volume":"3","author":"S Kang","year":"2020","unstructured":"Kang S, Moser VA, Svendsen CN, Goodridge HS (2020) Rejuvenating the blood and bone marrow to slow aging-associated cognitive decline and Alzheimer\u2019s disease. Commun Biol 3:69. https:\/\/doi.org\/10.1038\/s42003-020-0797-4","journal-title":"Commun Biol"},{"key":"12587_CR106","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.brainres.2015.02.011","volume":"1605","author":"T Kanamaru","year":"2015","unstructured":"Kanamaru T, Kamimura N, Yokota T et al (2015) Intravenous transplantation of bone marrow-derived mononuclear cells prevents memory impairment in transgenic mouse models of Alzheimer\u2019s disease. Brain Res 1605:49\u201358. https:\/\/doi.org\/10.1016\/j.brainres.2015.02.011","journal-title":"Brain Res"},{"key":"12587_CR107","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/s41593-024-01600-y","volume":"27","author":"R Mancuso","year":"2024","unstructured":"Mancuso R, Fattorelli N, Martinez-Muriana A et al (2024) Xenografted human microglia display diverse transcriptomic states in response to Alzheimer\u2019s disease-related amyloid-\u03b2 pathology. Nat Neurosci 27:886\u2013900. https:\/\/doi.org\/10.1038\/s41593-024-01600-y","journal-title":"Nat Neurosci"},{"key":"12587_CR108","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol Med 8:595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210","journal-title":"EMBO Mol Med"},{"key":"12587_CR109","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1248\/bpb.b25-00308","volume":"48","author":"M Sueyoshi","year":"2025","unstructured":"Sueyoshi M, Harada K, Okawa M et al (2025) Stimulation of \u03b17 Nicotinic Acetylcholine Receptors by PNU282987 Demonstrates Efferocytosis-Like Activation and Neuroprotection in Human Models of Microglia and Cholinergic Neurons under the Pathophysiological Conditions of Alzheimer\u2019s Disease. Biol Pharm Bull 48:972\u2013985. https:\/\/doi.org\/10.1248\/bpb.b25-00308","journal-title":"Biol Pharm Bull"},{"key":"12587_CR110","doi-asserted-by":"publisher","first-page":"102023","DOI":"10.1016\/j.tice.2023.102023","volume":"81","author":"M Takata","year":"2023","unstructured":"Takata M, Nishimura K, Harada K et al (2023) Analysis of A\u03b2-induced neurotoxicity and microglial responses in simple two- and three-dimensional human iPSC-derived cortical culture systems. Tissue Cell 81:102023. https:\/\/doi.org\/10.1016\/j.tice.2023.102023","journal-title":"Tissue Cell"},{"key":"12587_CR111","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.scr.2014.10.001","volume":"13","author":"K Takamatsu","year":"2014","unstructured":"Takamatsu K, Ikeda T, Haruta M et al (2014) Degradation of amyloid beta by human induced pluripotent stem cell-derived macrophages expressing Neprilysin-2. Stem Cell Res 13:442\u2013453. https:\/\/doi.org\/10.1016\/j.scr.2014.10.001","journal-title":"Stem Cell Res"},{"key":"12587_CR112","doi-asserted-by":"publisher","first-page":"e70071","DOI":"10.1002\/cti2.70071","volume":"15","author":"D Paasch","year":"2026","unstructured":"Paasch D, Schevel H, Riehle A et al (2026) Immune activation and response dynamics of human iPSC -derived macrophages in tuberculosis infection models. Clin Transl Immunol 15:e70071. https:\/\/doi.org\/10.1002\/cti2.70071","journal-title":"Clin Transl Immunol"},{"key":"12587_CR113","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13287-018-0800-x","volume":"9","author":"D Hong","year":"2018","unstructured":"Hong D, Ding J, Li O et al (2018) Human-induced pluripotent stem cell-derived macrophages and their immunological function in response to tuberculosis infection. Stem Cell Res Ther 9:49. https:\/\/doi.org\/10.1186\/s13287-018-0800-x","journal-title":"Stem Cell Res Ther"},{"key":"12587_CR114","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1038\/s41467-018-07570-7","volume":"9","author":"M Ackermann","year":"2018","unstructured":"Ackermann M, Kempf H, Hetzel M et al (2018) Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections. Nat Commun 9:5088. https:\/\/doi.org\/10.1038\/s41467-018-07570-7","journal-title":"Nat Commun"},{"key":"12587_CR115","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.3390\/ijms21072481","volume":"21","author":"A Lipus","year":"2020","unstructured":"Lipus A, Janosz E, Ackermann M et al (2020) Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages. Int J Mol Sci 21:2481. https:\/\/doi.org\/10.3390\/ijms21072481","journal-title":"Int J Mol Sci"},{"key":"12587_CR116","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.omtm.2021.03.002","volume":"21","author":"H Mashima","year":"2021","unstructured":"Mashima H, Zhang R, Kobayashi T et al (2021) Improved safety of induced pluripotent stem cell-derived antigen-presenting cell-based cancer immunotherapy. Mol Ther - Methods Clin Dev 21:171\u2013179. https:\/\/doi.org\/10.1016\/j.omtm.2021.03.002","journal-title":"Mol Ther - Methods Clin Dev"},{"key":"12587_CR117","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.omtn.2018.07.017","volume":"12","author":"K Higaki","year":"2018","unstructured":"Higaki K, Hirao M, Kawana-Tachikawa A et al (2018) Generation of HIV-Resistant Macrophages from IPSCs by Using Transcriptional Gene Silencing and Promoter-Targeted RNA. Mol Ther Nucleic Acids 12:793\u2013804. https:\/\/doi.org\/10.1016\/j.omtn.2018.07.017","journal-title":"Mol Ther Nucleic Acids"},{"key":"12587_CR118","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1016\/j.ymthe.2020.05.022","volume":"28","author":"N Kosaric","year":"2020","unstructured":"Kosaric N, Srifa W, Bonham CA et al (2020) Macrophage Subpopulation Dynamics Shift following Intravenous Infusion of Mesenchymal Stromal Cells. Mol Ther 28:2007\u20132022. https:\/\/doi.org\/10.1016\/j.ymthe.2020.05.022","journal-title":"Mol Ther"},{"key":"12587_CR119","doi-asserted-by":"publisher","first-page":"e0165748","DOI":"10.1371\/journal.pone.0165748","volume":"11","author":"N Kashiyama","year":"2016","unstructured":"Kashiyama N, Miyagawa S, Fukushima S et al (2016) Development of PET Imaging to Visualize Activated Macrophages Accumulated in the Transplanted iPSc-Derived Cardiac Myocytes of Allogeneic Origin for Detecting the Immune Rejection of Allogeneic Cell Transplants in Mice. PLoS ONE 11:e0165748. https:\/\/doi.org\/10.1371\/journal.pone.0165748","journal-title":"PLoS ONE"},{"key":"12587_CR120","doi-asserted-by":"publisher","first-page":"lnaf016","DOI":"10.1093\/lifemedi\/lnaf016","volume":"4","author":"Z Hong","year":"2025","unstructured":"Hong Z, Zhao Y, Pahlavan S et al (2025) iPSC modification strategies to induce immune tolerance. Life Med 4:lnaf016. https:\/\/doi.org\/10.1093\/lifemedi\/lnaf016","journal-title":"Life Med"},{"key":"12587_CR121","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40164-024-00549-9","volume":"13","author":"J Li","year":"2024","unstructured":"Li J, Chen P, Ma W (2024) The next frontier in immunotherapy: potential and challenges of CAR-macrophages. Exp Hematol Oncol 13:76. https:\/\/doi.org\/10.1186\/s40164-024-00549-9","journal-title":"Exp Hematol Oncol"},{"key":"12587_CR122","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/cells13070596","volume":"13","author":"C Sun","year":"2024","unstructured":"Sun C, Serra C, Kalicharan BH et al (2024) Challenges and Considerations of Preclinical Development for iPSC-Based Myogenic Cell Therapy. Cells 13:596. https:\/\/doi.org\/10.3390\/cells13070596","journal-title":"Cells"},{"key":"12587_CR123","doi-asserted-by":"publisher","unstructured":"Happle C, Lachmann N, Ackermann M et al (2017) Induced pluripotent stem cell derived macrophages differentiate into AM like cells in the lungs of humanized PAP mice. Eur Respir J 50(suppl 61):PA4177. https:\/\/doi.org\/10.1183\/1393003.congress-2017.PA4177","DOI":"10.1183\/1393003.congress-2017.PA4177"},{"key":"12587_CR124","doi-asserted-by":"publisher","unstructured":"Cerneckis J, Cai H, Shi Y (2024) Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications. Signal Transduct Target Ther 9. https:\/\/doi.org\/10.1038\/s41392-024-01809-0","DOI":"10.1038\/s41392-024-01809-0"},{"key":"12587_CR125","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3390\/jpm11060565","volume":"11","author":"J Dahlke","year":"2021","unstructured":"Dahlke J, Schott JW, Vollmer Barbosa P et al (2021) Efficient Genetic Safety Switches for Future Application of iPSC-Derived Cell Transplants. J Pers Med 11:565. https:\/\/doi.org\/10.3390\/jpm11060565","journal-title":"J Pers Med"},{"key":"12587_CR126","doi-asserted-by":"publisher","first-page":"101538","DOI":"10.1016\/j.omtm.2025.101538","volume":"33","author":"M Nakayama","year":"2025","unstructured":"Nakayama M, Moriya Y, Ueno H et al (2025) Considerations in biodistribution evaluation of iPSC-derived cell therapy: A pancreatic islet cell case study. Mol Ther Methods Clin Dev 33:101538. https:\/\/doi.org\/10.1016\/j.omtm.2025.101538","journal-title":"Mol Ther Methods Clin Dev"},{"key":"12587_CR127","doi-asserted-by":"publisher","first-page":"e1630","DOI":"10.1002\/wsbm.1630","volume":"16","author":"P Rispoli","year":"2024","unstructured":"Rispoli P, Scandiuzzi Piovesan T, Decorti G et al (2024) iPSCs as a groundbreaking tool for the study of adverse drug reactions: A new avenue for personalized therapy. WIREs Mech Dis 16:e1630. https:\/\/doi.org\/10.1002\/wsbm.1630","journal-title":"WIREs Mech Dis"},{"key":"12587_CR128","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13287-020-01644-4","volume":"11","author":"M Orzechowski","year":"2020","unstructured":"Orzechowski M, Schochow M, K\u00fchl M, Steger F (2020) Donor information in research and drug evaluation with induced pluripotent stem cells (iPSCs). Stem Cell Res Ther 11:126. https:\/\/doi.org\/10.1186\/s13287-020-01644-4","journal-title":"Stem Cell Res Ther"},{"key":"12587_CR129","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1093\/stcltm\/szae047","volume":"13","author":"D Terheyden-Keighley","year":"2024","unstructured":"Terheyden-Keighley D, H\u00fchne M, Berger T et al (2024) GMP-compliant iPS cell lines show widespread plasticity in a new set of differentiation workflows for cell replacement and cancer immunotherapy. Stem Cells Transl Med 13:898\u2013911. https:\/\/doi.org\/10.1093\/stcltm\/szae047","journal-title":"Stem Cells Transl Med"},{"key":"12587_CR130","doi-asserted-by":"publisher","first-page":"1719452","DOI":"10.3389\/fimmu.2025.1719452","volume":"16","author":"M De Homdedeu","year":"2026","unstructured":"De Homdedeu M, Escrib\u00e1 R, Rodr\u00edguez-Gonz\u00e1lez K et al (2026) Robust, scalable and xeno-free protocol for differentiating human induced pluripotent stem cells into functional macrophages. Front Immunol 16:1719452. https:\/\/doi.org\/10.3389\/fimmu.2025.1719452","journal-title":"Front Immunol"},{"key":"12587_CR131","doi-asserted-by":"publisher","first-page":"1627149","DOI":"10.3389\/fcell.2025.1627149","volume":"13","author":"S Dhaiban","year":"2025","unstructured":"Dhaiban S, Chandran S, Noshi M, Sajini AA (2025) Clinical translation of human iPSC technologies: advances, safety concerns, and future directions. Front Cell Dev Biol 13:1627149. https:\/\/doi.org\/10.3389\/fcell.2025.1627149","journal-title":"Front Cell Dev Biol"},{"key":"12587_CR132","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jcyt.2025.01.015","volume":"27","author":"J Takahashi","year":"2025","unstructured":"Takahashi J (2025) iPSC-based cell replacement therapy: from basic research to clinical application. Cytotherapy 27:835\u2013842. https:\/\/doi.org\/10.1016\/j.jcyt.2025.01.015","journal-title":"Cytotherapy"},{"key":"12587_CR133","doi-asserted-by":"publisher","first-page":"e007705","DOI":"10.1136\/jitc-2023-007705","volume":"11","author":"SM Abdin","year":"2023","unstructured":"Abdin SM, Paasch D, Kloos A et al (2023) Scalable generation of functional human iPSC-derived CAR-macrophages that efficiently eradicate CD19-positive leukemia. J Immunother Cancer 11:e007705. https:\/\/doi.org\/10.1136\/jitc-2023-007705","journal-title":"J Immunother Cancer"},{"key":"12587_CR134","doi-asserted-by":"publisher","first-page":"e70374","DOI":"10.1002\/mco2.70374","volume":"6","author":"W Ma","year":"2025","unstructured":"Ma W, Jamieson C (2025) Chimeric Antigen Receptor-Macrophage Therapy Enters the Clinic: The First\u2010in\u2010Human Trial for HER2+ Solid. Tumors MedComm 6:e70374. https:\/\/doi.org\/10.1002\/mco2.70374","journal-title":"Tumors MedComm"},{"key":"12587_CR135","doi-asserted-by":"publisher","first-page":"5244","DOI":"10.1158\/1538-7445.AM2024-5244","volume":"84","author":"K Haake","year":"2024","unstructured":"Haake K, Mirenda M, Bernard Q et al (2024) Abstract 5244: SIRP\u03b1 knockout iPSC-derived macrophages (iMACs) are resistant to CD47-dependent inhibition of phagocytosis and efficiently kill tumor cells in pre-clinical models. Cancer Res 84:5244\u20135244. https:\/\/doi.org\/10.1158\/1538-7445.AM2024-5244","journal-title":"Cancer Res"},{"key":"12587_CR136","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/cells8050403","volume":"8","author":"MX Doss","year":"2019","unstructured":"Doss MX, Sachinidis A (2019) Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications. Cells 8:403. https:\/\/doi.org\/10.3390\/cells8050403","journal-title":"Cells"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12587-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12587-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12587-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:11:09Z","timestamp":1786713069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12587-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":136,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12587"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12587-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1409"}}